Who owns APIMEDS PHARMACEUTICALS US I COM?
- Ticker: APUS
- CUSIP Number: 03771d102
Tip: Access positions for across all investors
Analyze quarterly positions in Apimeds Pharmaceuticals Us I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Apimeds Pharmaceuticals Us I stock
Who bought or sold APIMEDS PHARMACEUTICALS US I COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Hemenway Trust Company | 274k | $449k | 10% | Dec 2025 |
|
| Vanguard Group | 59k | $97k | 0% | Dec 2025 |
|
| Geode Capital Management | 35k | $57k | 13% | Dec 2025 |
|
| Jane Street | 27k | $45k | 100% | Dec 2025 |
|
| UBS Group | 582.00 | $954.014400 | 100% | Dec 2025 |
|
| Tower Research Capital | 10.00 | $16.000000 | 100% | Dec 2025 |
|
Who sold out of Apimeds Pharmaceuticals Us I?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Sep 2025 | 28k | $50k |
| XTX Topco | Sep 2025 | 19k | $33k |
| Hrt Financial | Sep 2025 | 14k | $24k |